RxDoctor Payments Data

Ahanth Vedantham, DPM

Podiatrist · Westchester, ILNPI 1124605712

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (40.4%), food and beverage and education — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Stryker at 29.9% of the total. 2025 is the largest year on record at $1,876, more than ten times the $111 reported in 2021.

$6,003in general payments, 2019–2025

Across 60 payments — averaging $100.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$2K
  • Orthofix Medical, Inc.$1K
  • Medwest Associates$1K
  • Integra Lifesciences Corporation$319
  • Linvatec Corporation$283
  • Amgen$235
  • plus $686 from 12 others

What the payments were for

  • Travel & lodging$2,42540%
  • Food & beverage$2,37840%
  • Education$1,20020%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,003 in reported general payments places this provider in the 85th percentile of 409 podiatrist providers in Illinois.

See all podiatrist providers in Illinois

Medicare billing

Part B allowed, 2024
$1,200,115
Medicare patients
379
Services billed
1,850

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav13$119

Paid to pharmacies, not to this prescriber.

Other podiatrist in Westchester

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →